Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study
Publication date: Available online 14 November 2026 Source: Nutrition, Metabolism and Cardiovascular Diseases Author(s): Yuhuan Tian, Shengwei Bai, Qiuyong Guo, Chong Sheng, Ming Wei, Jun Pan, Wenxue Liu, Dongjin Wang
Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study. // Nutrition, Metabolism & Cardiovascular Diseases. – URL: https://www.sciencedirect.com/science/article/pii/S0939475326005399?dgcid=rss_sd_all
Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study. Nutrition, Metabolism & Cardiovascular Diseases. https://www.sciencedirect.com/science/article/pii/S0939475326005399?dgcid=rss_sd_all
“Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study.” Nutrition, Metabolism & Cardiovascular Diseases.
@article{article60678,
title = {Clinical and Genetic Evidence for the Effects of Glucagon-like peptide-1 Receptor Agonists on Cardiovascular Phenotypes in Metabolic Disorders: An Integrated Meta-Analysis and Drug Target Mendelian Randomization Study},
journal = {Nutrition, Metabolism \& Cardiovascular Diseases},
url = {https://www.sciencedirect.com/science/article/pii/S0939475326005399?dgcid=rss_sd_all}
}